Safety and Efficacy of ARA 290 in Sarcoidosis Patients with Symptoms of Small Fiber Neuropathy: A Randomized, Double-Blind Pilot Study

ARA 290 (a peptide designed to activate the innate repair receptor that arrests injury and initiates cytoprotection, antiinflammation and healing) reduces allodynia in preclinical neuropathy models. We studied the safety and efficacy of ARA 290 to reduce symptoms of small fiber neuropathy (SFN) in p...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Heij, Lara, Niesters, Marieke, Swartjes, Maarten, Hoitsma, Elske, Drent, Marjolein, Dunne, Ann, Grutters, Jan C, Vogels, Oscar, Brines, Michael, Cerami, Anthony, Dahan, Albert
Formato: Artigo
Idioma:Inglês
Publicado: ScholarOne 2012
Assuntos:
Articles
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3563705/
https://ncbi.nlm.nih.gov/pubmed/23168581
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2119/molmed.2012.00332
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares